SPP 1089: Novel Vaccination Strategies
Subject Area
Medicine
Term
from 2000 to 2006
Project identifier
Deutsche Forschungsgemeinschaft (DFG) - Project number 5470124
Project Description
No abstract available
DFG Programme
Priority Programmes
Projects
Dendritic cell-based vaccination against infection: analysis of the parameters determining the protective of dendritic cells in the modell of leishmaniasis
(Applicant
Moll, Heidrun
)
Development of optimized adjuvant vectors for DNA vaccination
(Applicant
Haas, Jürgen
)
Development of protein-based subunit vaccines against Streptococcus pneumoniae
(Applicant
Chhatwal, Gursharan Singh
)
Development of Yersinia carrier systems for vaccination and investigation of cell-mediated Immune responses
(Applicant
Autenrieth, Ingo Birger
)
Development of Yersinia oral live carrier vaccine: Influence of the type III- secret/translocated effector proteins (Yops) on the immune response
(Applicant
Heesemann, Jürgen
)
Entwicklung einer oralen Amöbiasisvakzine unter Verwendung rekombinanter, attenuierter Yersinia enterocolitica
(Applicant
Tannich, Egbert
)
Generation and characterization of recombinant coxsackievirus replicons for prevention of virus-induced heart disease
(Applicant
Henke, Andreas
)
Identification of low-molecular mass ligands for targeting of subunit vaccines to Peyer`s patch M cells
(Applicant
Frey, Andreas
)
Identification of protective T-cell epitopes from intracellular bacteria from heat schock protein/peptide complexes
(Applicant
Kaufmann, Stefan H.E.
)
Immunisation protokolls utilising cpG-DNA coupled proteins for the activation of Dendritic Cells (DCs) with special emphasis on the cross-presentation/priming ability of plasmacytoid DCs
(Applicant
Wagner, Hermann
)
Impact of compartimentalized antigen expression by Mycobacterium bovis Bacille Calmette-Guérin (BCG) on the induction of T-cell mediated immunity
(Applicant
Hess, Jürgen
)
Induction of mucosal immune responses by the AIDA autotransporter-mediated presentation of heterologous antigenes in (commensal) live vectors
(Applicant
Schmidt, Marcus Alexander
)
Kombinierte CpG-Oligodeoxynukleotid/Lipopeptid Liposomen als neuer immunmodulatorischer Impfstoff gegen Hepatitis C Virus Infektion
(Applicant
Spengler, Ulrich
)
Kombinierte CpG-Oligodeoxynukleotid/Lipopeptid Liposomen als neuer immunmodulatorischer Impfstoff gegen Hepatitis C Virus Infektion
(Applicant
Will, Hans
)
Live vaccines based on virulence-attenuated Listera monocytogenes carrying novel plasmid vectors - a comparison of efficiency
(Applicant
Goebel, Werner
)
Native display of Borrelia antigens on the surface of hepatitis B virus capsids: Improved prophylactic and potential therapeutic vaccines against Lyme disease
(Applicant
Nassal, Michael
)
Native display of Borrelia antigens on the surface of hepatitis B virus capsids: Improved prophylactic and potential therapeutic vaccines against Lyme disease
(Applicant
Simon, Markus Michael
)
Oligodesoxynucleotides as adjuvants: Use in prophylactic and therapeutic vaccines
(Applicant
Zimmermann, Stefan
)
Oligodesoxynucleotides as adjuvants: Use in prophylactic and therapeutic vaccines
(Applicant
Heeg, Klaus Michael
)
Optimisation of host immune responses against vaccine antigens
(Applicant
Guzman, Ph.D., Carlos Alberto
)
Optimisation of recombinant Helicobacter pylori Ghosts for vaccination in H. pylori mouse and Mongolian Gerbil models
(Applicant
Haas, Rainer
)
Optimization of Salmonella-mediated oral vaccination
(Applicant
Weiß, Siegfried
)
Protective mechanism of Salmonella-based vaccination against Helicobacter pylori in mice
(Applicant
Meyer, Thomas F.
)
Recombinant live herpesvirus vaccines
(Applicant
Koszinowski, Ulrich H.
)
Recombinant Respiratory Syncytial Virus Vectors for Immunization of Respiratory Epithelia
(Applicant
Conzelmann, Karl-Klaus
)
Role of dendritic cells as adjuvants and carrier of microbial antigens in mucosal immunization
(Applicant
Beuscher, Horst Ulrich
)
Salmonella as a live carrier for recombinant vaccines: intracellular activated promoters
(Applicant
Hensel, Michael
)
Salmonella type III-mediated antigen targeting to induce cellular immunity: characterzition of effector and memory T cell populations after oral vaccination
(Applicant
Rüssmann, Holger
)
Spokesperson
Professor Dr. Stefan H.E. Kaufmann
